Storage and handling
Other information Phenylketonurics: Contains Phenylalanine 3.929 mg Per Tablet keep tightly sealed store between 20 to 25º C (68 to 77º F)
Other information Phenylketonurics: Contains Phenylalanine 3.929 mg Per Tablet keep tightly sealed store between 20 to 25º C (68 to 77º F)
Active ingredients (in each tablet)
Guaifenesin 100 mg
Purpose
Expectorant
Uses
helps loosen phlegm (mucus) and thin bronchial secretions to:
rid the bronchial passageways of bothersome mucus
make coughs more productive
Warnings
Ask a doctor before use if the user has
a persistent or chronic cough such as occurs with:
smoking
asthma
chronic bronchitis
emphysema
a cough that is accompanied by excessive phlegm (mucus)
a high fever
Stop use and ask a doctor if
any of the following occurs (these could be signs of a serious condition):
cough persists for more than 1 week
cough tends to recur
cough is accompanied by a fever, rash, or persistent headache
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children.In case of overdose, get medical help or contact a Poison Control Center right away.
Directions
adults and children 12 years of age and over: take 2 to 4 tablets every 4 hours, not to exceed 24 tablets (2,400 mg) in 24 hours
children 6 to under 12 years of age: take 1 to 2 tablets every 4 hours, not to exceed 12 tablets (1,200 mg) in 24 hours
children under 6 years of age: consult a doctor
Other information
Phenylketonurics: Contains Phenylalanine 3.929 mg Per Tablet
keep tightly sealed
store between 20 to 25º C (68 to 77º F)
Inactive ingredientsaspartame, colloidal silicon dioxide, corn starch, D&C yellow no.10 aluminum lake, lactose monohydrate, magnesium stearate, povidone K30, sodium starch glycolate.
Questions or comments?(888) 221-3496 M-F 9 am to 5 pm
you may also report serious side effects to this phone number
EXCAUGH
Guaifenesin - Expectorant
NDC 51467-009-02
36 Tablets
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 4fe95224-f543-4dbb-9445-8cca122b48c8 | Product name | 1 | 20150609 |
| e8718272-64cb-4436-969b-176c3067c8f4 | Product name | 1 | 20150609 |
| 106ff02a-57e1-4c4c-a307-fd582ff4e311 | Product name | 1 | 20150212 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 51467-009 | 51467-009-01, 51467-009-02 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| GUAIFENESIN | 495W7451VQ | ACTIB |
| ASPARTAME | Z0H242BBR1 | IACT |
| SILICON DIOXIDE | ETJ7Z6XBU4 | IACT |
| STARCH, CORN | O8232NY3SJ | IACT |
| D&C YELLOW NO. 10 | 35SW5USQ3G | IACT |
| LACTOSE MONOHYDRATE | EWQ57Q8I5X | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| POVIDONE K30 | U725QWY32X | IACT |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | 5856J3G2A2 | IACT |
| Version | Effective date | Source | Hydrated |
|---|---|---|---|
| 5 | 2025-11-13 | full-release | 2026-06-01 01:16:07 |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 438103e3-da3d-16c8-e063-6394a90ad7f3 | 60803d28-ea6e-4ab9-9cc9-4909b4681ecd | 2025-11-13 | Warnings | 60803d28-ea6e-4ab9-9cc9-4909b4681ecd |
Adverse event summaries are temporarily unavailable. Other product information remains available.